Karen Durrant

993 citations
8 papers · 70 indexed · h-index 4
Topics
Inflammasome and immune disorders (4 papers)IL-33, ST2, and ILC Pathways (2 papers)COVID-19 and healthcare impacts (2 papers)
Journals
SHILAP Revista de lepidopterologíaAnnals of the Rheumatic DiseasesBMJ Open

In The Last Decade

Karen Durrant

7 papers receiving 68 citations

Peers

Karen Durrant
Comparison fields: 5 of 50
  • Pharmacology 25
  • Molecular Biology 19
  • Hematology 14
  • Public Health, Environmental and Occupational Health 11
  • Clinical Psychology 10
Replace Ayman Mofti with:
Ayman Mofti Singapore
S. Mingolla Switzerland
William J Gregory United Kingdom
Ansgar Weyergraf Germany
Zeinab Moinfar Iran
Antoine Baldassari United States
Ricardo Teijeiro Mexico
С А Сиверцева Russia
Annika Faucon United States
Chiyoko Kono Japan
Karen Durrant relative to Ayman Mofti Singapore Ayman Mofti's profile →
Citations per field
00.5×9.5×
Ayman Mofti · 1×
Citations per year

Countries citing papers authored by Karen Durrant

Since Specialization
Citations

This map shows the geographic impact of Karen Durrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Durrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Durrant more than expected).

Fields of papers citing papers by Karen Durrant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Durrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Durrant. The network helps show where Karen Durrant may publish in the future.

Co-authorship network of co-authors of Karen Durrant

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Durrant. A scholar is included among the top collaborators of Karen Durrant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Durrant. Karen Durrant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 2
2 17
3 2
4 1
5 15
6 0
7 7
8 26

About Karen Durrant

Karen Durrant is a scholar working on Rehabilitation, Hematology and Speech and Hearing, having authored 8 papers that have together received 70 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (4 papers), IL-33, ST2, and ILC Pathways (2 papers) and COVID-19 and healthcare impacts (2 papers). The work is most often cited by research in Pharmacology (25 citations), Hematology (14 citations) and Rheumatology (9 citations). Karen Durrant has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Kathleen G. Lomax, Jonathan S. Hausmann, Toby O. Smith, Nienke M. ter Haar, Ornella Della Casa Alberighi, Raphaela Goldbach‐Mansky, Seza Özen, Kim V. Annink, Jacqueline R. Chipping and Marco Gattorno. Their work appears in journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and BMJ Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026